In this episode of Frost & Sullivan’s Growth Podcast, we explore how electroceuticals are transforming chronic disease management—from pain to neurodegeneration. With wearable formats, AI-driven personalization, and hybrid therapy models, this market is scaling fast and redefining long-term care.

🎯 Key takeaways include:

• How electroceuticals offer scalable, non-invasive alternatives to chronic drug use

• Role of AI in driving real-time therapy optimization and patient-specific outcomes

• Top innovators including Boston Scientific, Sinaptica, and Nalu Medical

• Why multimodal systems are the next leap in non-pharmacological care

• Business and investment opportunities shaping the bioelectronic medicine frontier

This episode is essential for leaders across medtech, digital therapeutics, and chronic care innovation.

frost.com | [email protected]